Wang CF, Wang ZY, Li JY. Dual protective role of HO-1 in transplanted liver grafts: A review of experimental and clinical studies. World J Gastroenterol 2011; 17(26): 3101-3108 [PMID: 21912452 DOI: 10.3748/wjg.v17.i26.3101]
Corresponding Author of This Article
Ji-Yu Li, PhD, Department of General Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China. leejiyu@sina.com
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Jul 14, 2011 (publication date) through Oct 25, 2025
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Wang CF, Wang ZY, Li JY. Dual protective role of HO-1 in transplanted liver grafts: A review of experimental and clinical studies. World J Gastroenterol 2011; 17(26): 3101-3108 [PMID: 21912452 DOI: 10.3748/wjg.v17.i26.3101]
World J Gastroenterol. Jul 14, 2011; 17(26): 3101-3108 Published online Jul 14, 2011. doi: 10.3748/wjg.v17.i26.3101
Dual protective role of HO-1 in transplanted liver grafts: A review of experimental and clinical studies
Chun-Feng Wang, Zhen-Yu Wang, Ji-Yu Li
Chun-Feng Wang, Zhen-Yu Wang, Ji-Yu Li, Department of General Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China
Author contributions: Wang CF, Wang ZY and Li JY contributed equally to this work; Li JY and Wang ZY conceived the paper and made some good suggestions; Wang CF wrote the paper.
Supported by The grants for Young Scientist Project, National Natural Science Foundation of China, No. 30600598; “Qi Ming Star for Young Scientist” Project, Science and Technology Commission of Shanghai Municipality, No. 10QH1401800; “Shu Guang Scholar” Project, Shanghai Municipal Educational Commission, No. 10SG20; the Key Medical Project of Science and Technology Commission of Shanghai Municipality, No. 09411952500; Nano-specific Project of Science and Technology Commission of Shanghai Municipality, Project No. 0952nm03800; and Research and Innovation Project of Shanghai Municipal Education Commission, Project No. 09YZ103
Correspondence to: Ji-Yu Li, PhD, Department of General Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China. leejiyu@sina.com
Received: January 18, 2011 Revised: February 2, 2011 Accepted: February 9, 2011 Published online: July 14, 2011
Abstract
Liver transplantation is considered as the most effective treatment for end-stage liver disease. However, serious complications still exist, particularly in two aspects: ischemia and subsequent reperfusion of the liver, causing postoperative hepatic dysfunction and even failure; and acute and chronic graft rejections, affecting the allograft survival. Heme oxygenase (HO), a stress-response protein, is believed to exert a protective function on both the development of ischemia-reperfusion injury (IRI) and graft rejection. In this review of current researches on allograft protection, we focused on the HO-1. We conjecture that HO-1 may link these two main factors affecting the prognosis of liver transplantations. In this review, the following aspects were emphasized: the basic biological functions of HO-1, its roles in IRI and allograft rejection, as well as methods to induce HO-1 and the prospects of a therapeutic application of HO-1 in liver transplantation.
